* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 2932 | GSK3B | C0011581 | Depressive disorder | 0.480274726784213 | BEFREE;CTD_human;PSYGENET;RGD |
| 2932 | GSK3B | C0005586 | Bipolar Disorder | 0.421845438936164 | BEFREE;CTD_human;GAD;LHGDN;PSYGENET |
| 2932 | GSK3B | C0002395 | Alzheimer's Disease | 0.31313168349158 | BEFREE;CTD_human;GAD;LHGDN;RGD |
| 2932 | GSK3B | C0027051 | Myocardial Infarction | 0.280274726784213 | BEFREE;CTD_human;RGD |
| 2932 | GSK3B | C0018800 | Cardiomegaly | 0.28 | CTD_human;RGD |
| 2932 | GSK3B | C0020538 | Hypertensive disease | 0.28 | CTD_human;RGD |
| 2932 | GSK3B | C0036341 | Schizophrenia | 0.224782980030229 | BEFREE;CTD_human;GAD;LHGDN |
| 2932 | GSK3B | C0033578 | Prostatic Neoplasms | 0.208473464178654 | BEFREE;CTD_human;LHGDN |
| 2932 | GSK3B | C0011570 | Mental Depression | 0.207495812354077 | BEFREE;GAD;PSYGENET |
| 2932 | GSK3B | C1269683 | Major Depressive Disorder | 0.205154296365419 | BEFREE;GAD;PSYGENET |
| 2932 | GSK3B | C0525045 | Mood Disorders | 0.20328236603324 | BEFREE;LHGDN;PSYGENET |
| 2932 | GSK3B | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.202732912464814 | CTD_human;LHGDN |
| 2932 | GSK3B | C0018801 | Heart failure | 0.2 | CTD_human |
| 2932 | GSK3B | C0026846 | Muscular Atrophy | 0.2 | CTD_human |
| 2932 | GSK3B | C0031154 | Peritonitis | 0.2 | CTD_human |
| 2932 | GSK3B | C0993582 | Arthritis, Experimental | 0.2 | CTD_human |
| 2932 | GSK3B | C1866282 | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 0.2 | CTD_human |
| 2932 | GSK3B | C2609414 | Acute kidney injury | 0.2 | CTD_human |
| 2932 | GSK3B | C0030567 | Parkinson Disease | 0.0927012658768088 | BEFREE;GAD;LHGDN;RGD |
| 2932 | GSK3B | C0596263 | Carcinogenesis | 0.0821978142737048 | BEFREE;RGD |
| 2932 | GSK3B | C0027055 | Myocardial Reperfusion Injury | 0.08 | RGD |
| 2932 | GSK3B | C0038220 | Status Epilepticus | 0.08 | RGD |
| 2932 | GSK3B | C0243026 | Sepsis | 0.08 | RGD |
| 2932 | GSK3B | C0030297 | Pancreatic Neoplasm | 0.010931649859255 | LHGDN |
| 2932 | GSK3B | C2239176 | Liver carcinoma | 0.0108948480792596 | BEFREE;GAD;LHGDN |
| 2932 | GSK3B | C0032460 | Polycystic Ovary Syndrome | 0.00837114986402905 | BEFREE;GAD;LHGDN |
| 2932 | GSK3B | C0006142 | Malignant neoplasm of breast | 0.0059129641834284 | BEFREE;GAD |
| 2932 | GSK3B | C0009375 | Colonic Neoplasms | 0.0054658249296275 | LHGDN |
| 2932 | GSK3B | C0013386 | Dyskinesia, Drug-Induced | 0.004814057046576 | GAD |
| 2932 | GSK3B | C0524851 | Neurodegenerative Disorders | 0.00328236603323995 | BEFREE;LHGDN |
| 2932 | GSK3B | C0242379 | Malignant neoplasm of lung | 0.0032312088759273 | BEFREE;GAD |
| 2932 | GSK3B | C0009402 | Colorectal Carcinoma | 0.0030219946263441 | BEFREE |
| 2932 | GSK3B | C0001418 | Adenocarcinoma | 0.00300763924902685 | BEFREE;LHGDN |
| 2932 | GSK3B | C0019163 | Hepatitis B | 0.00300763924902685 | BEFREE;LHGDN |
| 2932 | GSK3B | C0023473 | Myeloid Leukemia, Chronic | 0.00300763924902685 | BEFREE;LHGDN |
| 2932 | GSK3B | C0025202 | melanoma | 0.00300763924902685 | BEFREE;LHGDN |
| 2932 | GSK3B | C0497327 | Dementia | 0.00300763924902685 | BEFREE;LHGDN |
| 2932 | GSK3B | C1527249 | Colorectal Cancer | 0.002747267842131 | BEFREE |
| 2932 | GSK3B | C0005699 | Blast Phase | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0025149 | Medulloblastoma | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0025517 | Metabolic Diseases | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0038356 | Stomach Neoplasms | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0333641 | Atrophic | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0919267 | ovarian neoplasm | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C1292753 | Primary Effusion Lymphoma | 0.00273291246481375 | LHGDN |
| 2932 | GSK3B | C0005684 | Malignant neoplasm of urinary bladder | 0.0026817553075011 | BEFREE;GAD |
| 2932 | GSK3B | C0376358 | Malignant neoplasm of prostate | 0.0024725410579179 | BEFREE |
| 2932 | GSK3B | C0600139 | Prostate carcinoma | 0.0024725410579179 | BEFREE |
| 2932 | GSK3B | C0005940 | Bone Diseases | 0.002407028523288 | GAD |
| 2932 | GSK3B | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
| 2932 | GSK3B | C0026650 | Movement Disorders | 0.002407028523288 | GAD |
| 2932 | GSK3B | C0026764 | Multiple Myeloma | 0.002407028523288 | GAD |
| 2932 | GSK3B | C0043094 | Weight Gain | 0.002407028523288 | GAD |
| 2932 | GSK3B | C1512411 | Hepatocellular Carcinoma of the Mouse | 0.002407028523288 | GAD |
| 2932 | GSK3B | C2911647 | Weight Gain Adverse Event | 0.002407028523288 | GAD |
| 2932 | GSK3B | C0032580 | Adenomatous Polyposis Coli | 0.0021978142737048 | BEFREE |
| 2932 | GSK3B | C0027627 | Neoplasm Metastasis | 0.0019230874894917 | BEFREE |
| 2932 | GSK3B | C0002726 | Amyloidosis | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0007102 | Malignant tumor of colon | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0007131 | Non-Small Cell Lung Carcinoma | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0041696 | Unipolar Depression | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0178874 | Tumor Progression | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0678222 | Breast Carcinoma | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0699790 | Colon Carcinoma | 0.0010989071368524 | BEFREE |
| 2932 | GSK3B | C0007134 | Renal Cell Carcinoma | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0029463 | Osteosarcoma | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0235974 | Pancreatic carcinoma | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0346647 | Malignant neoplasm of pancreas | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0585442 | Osteosarcoma of bone | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0684249 | Carcinoma of lung | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C1306460 | Primary malignant neoplasm of lung | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0008241803526393 | BEFREE |
| 2932 | GSK3B | C0001430 | Adenoma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0003850 | Arteriosclerosis | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0004153 | Atherosclerosis | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0007137 | Squamous cell carcinoma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0017636 | Glioblastoma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0017638 | Glioma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0020179 | Huntington Disease | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0023418 | leukemia | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0023467 | Leukemia, Myelocytic, Acute | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0024623 | Malignant neoplasm of stomach | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0338656 | Impaired cognition | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0494463 | Alzheimer Disease, Late Onset | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0598766 | Leukemogenesis | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0699791 | Stomach Carcinoma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0949664 | Tauopathies | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C2931822 | Nasopharyngeal carcinoma | 0.0005494535684262 | BEFREE |
| 2932 | GSK3B | C0004936 | Mental disorders | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0005587 | Depression, Bipolar | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0005695 | Bladder Neoplasm | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0006287 | Bronchopulmonary Dysplasia | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0011847 | Diabetes | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0011849 | Diabetes Mellitus | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0011881 | Diabetic Nephropathy | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0013274 | Patent ductus arteriosus | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0014859 | Esophageal Neoplasms | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0015625 | Fanconi Anemia | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0019158 | Hepatitis | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0021294 | Infant, Premature | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0021670 | insulinoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0022680 | Polycystic Kidney Diseases | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0023434 | Chronic Lymphocytic Leukemia | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0023487 | Acute Promyelocytic Leukemia | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0023890 | Liver Cirrhosis | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0027819 | Neuroblastoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0029925 | Ovarian Carcinoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0030552 | Paresis | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0032000 | Pituitary Adenoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0036421 | Systemic Scleroderma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0039101 | synovial sarcoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0040100 | Thymoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0042769 | Virus Diseases | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0079541 | Holoprosencephaly | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0151786 | Muscle Weakness | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0152013 | Adenocarcinoma of lung (disorder) | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0152018 | Esophageal carcinoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0154409 | Recurrent major depressive episodes | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0162557 | Liver Failure, Acute | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0233514 | Abnormal behavior | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0236642 | Pick Disease of the Brain | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0268575 | Isovaleryl-CoA dehydrogenase deficiency | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0276496 | Familial Alzheimer Disease (FAD) | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0338106 | Adenocarcinoma of colon | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0338451 | Frontotemporal dementia | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0338831 | Manic | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0346957 | Disseminated Malignant Neoplasm | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0400966 | Non-alcoholic Fatty Liver Disease | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0442874 | Neuropathy | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0546837 | Malignant neoplasm of esophagus | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0677932 | Progressive Neoplastic Disease | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0685938 | Malignant neoplasm of gastrointestinal tract | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0687150 | Parathyroid Gland Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0699885 | Carcinoma of bladder | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0700095 | Central neuroblastoma | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0730328 | Central Serous Chorioretinopathy | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C0853193 | Bipolar I disorder | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1140680 | Malignant neoplasm of ovary | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1263846 | Attention deficit hyperactivity disorder | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1270972 | Mild cognitive disorder | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1800706 | Idiopathic Pulmonary Fibrosis | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1839839 | MAJOR AFFECTIVE DISORDER 2 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1852197 | MAJOR AFFECTIVE DISORDER 1 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1970943 | MAJOR AFFECTIVE DISORDER 4 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C1970945 | MAJOR AFFECTIVE DISORDER 6 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C2700438 | MAJOR AFFECTIVE DISORDER 7 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C2700439 | MAJOR AFFECTIVE DISORDER 8 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C2700440 | MAJOR AFFECTIVE DISORDER 9 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C3250443 | MYOTONIC DYSTROPHY 1 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C3489791 | Parkinson Disease, Familial, Type 1 | 0.0002747267842131 | BEFREE |
| 2932 | GSK3B | C3539781 | Progressive cGVHD | 0.0002747267842131 | BEFREE |